By Sergei Zaslavsky (June 23, 2020, 5:18 PM EDT) -- "Killer acquisitions," transactions involving nascent competitors, and other potential competition theories of harm have been a hot topic in antitrust enforcement circles, particularly when the acquirer is a large technology company.
U.S. Department of Justice officials have discussed extending the use of Sherman Act Section 2 to go after acquisitions of potential competitors that may not be actionable under Clayton Act Section 7, the statute traditionally used to block anti-competitive mergers.
The Federal Trade Commission has announced it is studying nonreportable acquisitions consummated by big tech firms over the past decade. An FTC commissioner recently mentioned that the agency expects to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!